Page 50 - Read Online
P. 50

Ornaghi et al. Mini-invasive Surg 2021;5:42  https://dx.doi.org/10.20517/2574-1225.2021.50  Page 5 of 17



                                                  LN yield was higher for RARC compared with
                                                  ORC, with a median of 27 nodes (IQR 7-57)
                                                  compared with 20.5 nodes (IQR 0-57) (P <
                                                  0.001). The overall rate of N+ disease was low
                                                  between both groups (P = 0.89)
                                                  The overall complication rate was 75.4%, with
                                                  no difference in rates between groups (76.3%
                                                  vs. 73.9%, respectively, P = 0.83)
                                                  The majority of complications (89.5% vs.
                                                  82.3%) were < 3 CCS complications
                                                  Overall 30- and 90-day readmission rates were
                                                  24% and 29.8%, respectively, with no difference
                                                  observed between ORC or RARC groups (P =
                                                  0.67 and P = 0.68)
 [17]
 Whittum et al.  ,   Retrospective   118  RARC  Median of 9  IC (106); others  Age, BMI, ASA score,   - Surgical: OT, type of UD,  17 patients (14%) showed a gynecological organ
 2018   (monocentric   months (IQR  (12)  NAC, prior   EBL, ICU, LOS, 30- and 90- invasion at pathological specimen. These
 study)  6-13) for   abdominal/pelvic   day complications, 30- and  patients had more LVI at TURBT (82% vs. 46%,
 organ   surgery, prior RT, LVI   90-day readmission;   P = 0.006), trigonal tumours at TURBT (59% vs.
 invasion; 23   at TURBT, tumor site   - Pathological: pT stage   18%, P = 0.001), multifocal disease (65% vs.
 months (IQR   at TURBT, histology at  (gynecological organ   33%, P = 0.01), (71% vs. 22%, P < 0.001), PSMs
 8-45) for no   TURBT     invasion), pN stage,    (24% vs. 4%; P = 0.02), and they less commonly
 organ                    histology, PSMs;        demonstrated pure urothelial carcinoma at
 invasion                 - Oncological: AC; 30- and  TURBT (18% vs. 66%, P < 0.001)
                          90-day OS               There was no statistically significant difference
                                                  between the two groups in terms of hospital or
                                                  ICU stay, complications, readmissions, mortality
                                                  at 30 and 90 days
                                                  On multivariate analysis, significant predictors of
                                                  gynecological organ invasion were pN positive
                                                  disease (OR 6.48, 95%CI: 1.64-25.51, P =
                                                  0.008), trigonal tumour location (OR 5.72, 95%
                                                  CI: 1.39-23.61, P = 0.02), and presence of variant
                                                  histology (OR 18.52, 95%CI: 3.32-103.4, P =
                                                  0.001)
 [22]
 Tyritzis et al.  ,   Retrospective   70 (62 male, 8   RARC (nerve   Median of   iN  Age, sex, BMI, ASA   - Surgical: OT, type of   They recorded negative margins in 69 of 70
 2013   (monocentric   female)  sparing-RARC in  30.3 months   score, preoperative   PLND, nerve sparing, EBL,  patients (98.6%). Clavien 3-5 complications
 study)  all female)  (IQR 12.7-  TNM, preoperative   LOS, ≥ 30-day/90-day   occurred in 22/70 patients (31.4%) at 30-day
 35.6)  grade, concomitant   complications according to  and 13/70 (18.6%) at > 30-day. At 90-day, the
     CIS, NAC.            CCS;                    overall complication rate was 58.5%. Clavien < 3
                          - Pathological: pT stage,   and Clavien ≥ 3 complications were recorded in
                          pN stage, concomitant CIS,  15/70 patients (21.4%) and 26/70 (37.1%),
                          PSMs, GS, LN yield;     respectively
                          - Oncological: 24-month   Kaplan-Meier estimates for RFS, CSS and OS at
                          recurrence, recurrence   24 months were 80.7%, 88.9%, and 88.9%,
                          location, RFS, CCS, OS;   respectively
                          - Functional: 6/12-month   Daytime and nighttime continence at 12 months
                          daytime and nighttime   reaches 80%-90% in men and 70% women. At
                          continence (≤ 1 pad/die),   12 months, 46 men (74.2%) and 2 of 3 evaluable
                          6/12-month potency and   females (66.7%) were continent. One female
   45   46   47   48   49   50   51   52   53   54   55